Stephen D. Newlin - 25 Nov 2022 Form 4 Insider Report for Univar Solutions Inc.

Role
Director
Signature
/s/ Noelle J. Perkins as Attorney-in-Fact for Stephen D. Newlin
Issuer symbol
N/A
Transactions as of
25 Nov 2022
Net transactions value
-$4,592,235
Form type
4
Filing time
29 Nov 2022, 16:37:38 UTC
Previous filing
15 Nov 2022
Next filing
03 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UNVR Common Stock Options Exercise $1,087,500 +50,000 +31% $21.75 209,933 25 Nov 2022 Direct F1
transaction UNVR Common Stock Sale $1,600,300 -50,000 -24% $32.01 159,933 25 Nov 2022 Direct F1
transaction UNVR Common Stock Options Exercise $1,087,500 +50,000 +31% $21.75 209,933 28 Nov 2022 Direct F1
transaction UNVR Common Stock Sale $1,645,430 -50,000 -24% $32.91 159,933 28 Nov 2022 Direct F1
transaction UNVR Common Stock Options Exercise $151,598 +6,970 +4.4% $21.75 166,903 29 Nov 2022 Direct F1
transaction UNVR Common Stock Sale $225,535 -6,970 -4.2% $32.36 159,933 29 Nov 2022 Direct F1
holding UNVR Common Stock 28,892 25 Nov 2022 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UNVR Stock Options (right to buy) Options Exercise $1,600,300 -50,000 -47% $32.01 56,970 25 Nov 2022 Common Stock 50,000 $21.75 Direct F1, F2
transaction UNVR Stock Options (right to buy) Options Exercise $1,617,895 -50,000 -88% $32.36 6,970 28 Nov 2022 Common Stock 50,000 $21.75 Direct F1, F2
transaction UNVR Stock Options (right to buy) Options Exercise $229,373 -6,970 -100% $32.91 0 29 Nov 2022 Common Stock 6,970 $21.75 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on May 11, 2022. A portion of the proceeds from these sales will be used to cover the Reporting Person's tax liability arising from the option exercise.
F2 All shares underlying this option have vested.